Randal D. Chase serves as Executive at BIOJECT MEDICAL TECHNOLOGIES INC, where they oversee executive responsibilities. Since joining the company, Randal D. Chase has executed 16 insider transactions totaling $147.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 21, 2022 involved purchasing 10,000 shares valued at $11.0K.
Randal D. Chase currently holds 36,613 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randal D. Chase has been a net buyer of BJCT stock. They have purchased $147.0K and sold $0 worth of shares.
Randal D. Chase's most recent insider trade was on Sep 21, 2022, when they purchased 10,000 shares at $1.10 per share.
Get notified when new Form 4 filings are submitted
| $1.21 |
| Discretionary |
| Sep 29, 2020 | GOVX | $83.1K | Purchase | 16,613 | $5.00 | Discretionary |
| May 5, 2015 | GOVX | $38 | Purchase | 200 | $0.19 | Discretionary |
| May 5, 2015 | GOVX | $1.9K | Purchase | 9,800 | $0.19 | Discretionary |
| Apr 20, 2015 | GOVX | $5.1K | Purchase | 30,000 | $0.17 | Discretionary |
| Jun 5, 2009 | BJCT | $0 | Option Exercise | 19,000 | $N/A | Discretionary |
| Dec 5, 2008 | BJCT | $0 | Option Exercise | 19,000 | $N/A | Discretionary |
| Jun 14, 2008 | BJCT | $0 | Option Exercise | 12,000 | $N/A | Discretionary |
| Dec 14, 2007 | BJCT | $0 | Option Exercise | 12,000 | $N/A | Discretionary |
| Jun 14, 2007 | BJCT | $6.8K | Purchase | 5,084 | $1.33 | Discretionary |
| Jun 14, 2007 | BJCT | $6.8K | Purchase | 4,916 | $1.39 | Discretionary |
| May 24, 2007 | BJCT | $0 | Option Exercise | 4,750 | $N/A | Discretionary |
| Nov 27, 2006 | BJCT | $0 | Option Exercise | 4,750 | $N/A | Discretionary |
| Nov 27, 2006 | BJCT | $0 | Option Exercise | 4,750 | $N/A | Discretionary |
| Jun 7, 2006 | BJCT | $20.3K | Purchase | 15,000 | $1.35 | Discretionary |